Intrinsic Value of S&P & Nasdaq Contact Us

Intersect ENT, Inc. XENT NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
27/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Intersect ENT, Inc. (XENT) has 20 known insider and institutional holders on record. The largest holder is Presidio Management Group IX, L.L.C. with 1,995,433 shares. Other notable holders include Anderson Rick D and PTV SCIENCES II L P.

XENT Insider Ownership

Top Holder
Presidio Management Group IX, L.L.C.
1,995,433 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Presidio Management Group Ix, L.l.c. 10 Percent Owner 1,995,433 2015-05-11
100%
2 Anderson Rick D 10 Percent Owner 1,932,724 2015-01-20
97%
3 Ptv Sciences Ii L P 10 Percent Owner 1,932,724 2015-01-20
97%
4 Kleiner Perkins Caufield & Byers Xi-a Lp 10 Percent Owner 1,748,589 2015-05-12
88%
5 De Clercq Casper L. Director 600,120 2015-05-14
30%
6 Meier Richard A EVP & Chief Financial Officer 165,925 2022-02-04
8%
7 Earnhardt Lisa D President and CEO 140,000 2019-05-17
7%
8 Mckhann Chas Chief Commercial Officer 55,000 2016-01-20
3%
9 Hilleman Jeryl L Chief Financial Officer 43,836 2019-05-08
2%
10 Kowalski Christine R EVP & Chief Operating Officer 41,042 2021-02-08
2%
11 Binney Robert H Jr Chief Commercial Officer 37,555 2020-03-04
2%
12 Fernandez Reyna M Chief Human Resource Officer 31,576 2022-02-03
2%
13 Stambaugh James VP Clinical Affairs 23,700 2016-09-07
1%
14 Lehman David Aaron EVP & General Counsel 21,270 2020-02-05
1%
15 Sandoval Elisabeth Director 15,896 2021-04-07
1%
16 Moll Frederic H Director 9,666 2020-06-08
0%
17 Vernon W Anthony Director 9,666 2020-06-08
0%
18 Stimson Susan P Chief Strategy Officer 6,550 2019-06-17
0%
19 Lucchese Cynthia L Director 5,734 2021-06-07
0%
20 Kline Teresa L. Director 5,734 2021-06-07
0%

No ownership data available for XENT.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message